Oligo Supplier Acquired
This is OriGene’s second acquisition in a year (see IBO 10/31/09). Blue Heron becomes the second oligonucleotide company to be sold so far this year, following Life Technologies’ acquisition of GENEART AG (see IBO 4/30/10).
Rockville, MD 8/12/10—OriGene Technologies has acquired Blue Heron Biotechnology, a gene synthesis company. “We are 100% committed to serving our customers with high-quality, strict confidentiality standards and improved business efficiency,” commented OriGene Chairman and CEO Dr. Wei-Wu He. “This latest purchase is a further indication of OriGene’s determination to expand its gene-centric tools portfolio for the life sciences research and drug discovery community.” OriGene supplies products that support research of gene functions and drug discovery.